{"slideshow_credits": null, "snippet": "The deal for Sprout Pharmaceuticals came after the Food and Drug Administration granted approval this week for Addyi, a new libido drug for women.", "abstract": "Valeant Pharmaceuticals International will acquire Sprout Pharmaceuticals for about $1 billion; deal comes nearly week after Food and Drug Administration granted Sprout approval for Addyi, new libido-enhancing drug for women.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}, {"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 2, "organization": ""}], "original": "By ANDREW POLLACK and CHAD BRAY"}, "web_url": "http://www.nytimes.com/2015/08/21/business/dealbook/valeant-pharmaceuticals-to-buy-sprout-maker-of-addyi-female-viagra-drug.html", "lead_paragraph": "The deal for Sprout Pharmaceuticals came after the Food and Drug Administration granted approval this week for Addyi, a new libido drug for women.", "headline": {"main": "Maker of Addyi, \u2018Female Viagra\u2019 Drug, Being Sold to Valeant for $1 Billion", "print_headline": "Valeant Buys Company That Makes Libido Drug "}, "_id": "55d5c40338f0d84ac8725c16", "word_count": "1117", "multimedia": [{"height": 126, "url": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 378, "url": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-articleLarge-v2.jpg", "xlargewidth": "600", "xlargeheight": "378"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/08/21/business/dbpix-sprout2/dbpix-sprout2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-08-21T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Sprout Pharmaceuticals Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Addyi (Drug)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}